news2023-03-09T13:10:55+01:00

news

TAmiRNA @ Precision Medicine EV Forum

TAmiRNA to Exhibit at the Precision Medicine EV Forum 2025 in Cambridge Vienna, October 2025 – TAmiRNA GmbH, a leading provider of extracellular vesicle (EV) transcriptomic services, is pleased to announce its participation as an exhibitor at the Precision Medicine EV Forum 2025, taking place in Cambridge, UK, from October 27th to 28th. The forum, a key event focused on the translational aspects [...]

hepatoMX Project Kickoff: TAmiRNA and You2Yourself Join Forces to Develop a Groundbreaking Urinary microRNA Diagnostic for Liver Disease

We are excited to announce the official start of the EUREKA Eurostars project hepatoMX — a three-year collaboration between You2Yourself (Y2Y), a Dutch company specializing in small RNA-based early disease detection, and TAmiRNA GmbH, an Austrian SME with expertise in microRNA biomarker discovery and diagnostic test development (hepatomiR®). The project officially started on April 1, 2025, and aims to revolutionize the early detection [...]

By |October 14th, 2025|Categories: biomarker, Biomarker Discovery, biomarkers, hepatoMX, Illumina NewSeq2000, microRNA services, microRNAs, miND, miND spike ins, NGS, sequencing, small RNA-sequencing, smallRNA|Tags: , , , , , , , , , , , |Comments Off on hepatoMX Project Kickoff: TAmiRNA and You2Yourself Join Forces to Develop a Groundbreaking Urinary microRNA Diagnostic for Liver Disease

Microvascular microRNA Signatures in Sepsis: A High-Resolution View

Sepsis drives profound microvascular injury, particularly in the kidney. But how do microRNAs (miRNAs) - the small regulators of gene expression - respond within distinct vascular compartments during this insult? A new study by Luxen et al.  published in Scientific Reports on October 2nd 2025 takes on this question using a clever methodological combination: laser microdissection (LMD) of microvascular subregions (arterioles, glomeruli, capillaries, [...]

TAmiRNA @ GSEV 2025

TAmiRNA Announces Gold Sponsorship of GSEV Autumn Meeting 2025 and Presentation by Matthias Hackl TAmiRNA, a pioneer in transcriptomics-based biomarker research, is proud to announce its participation as a Gold Sponsor at the GSEV Autumn Meeting 2025, hosted by the German Society for Extracellular Vesicles (GSEV). The annual conference will take place on September 25–26, 2025, at the Audimax of the University Hospital [...]

TAmiRNA @ EBJIS 2025

TAmiRNA is proud to announce its participation at the upcoming European Bone and Joint Infection Society (EBJIS) Meeting 2025 in Ferrara, Italy. On Thursday, September 11, 2025 at 11:00 (Sala Emilia), Dr. Bernhard JH Frank will present groundbreaking new results from a collaborative study conducted with the Orthopaedic Hospital Speising and Dr. Jochen G. Hofstätter. The presentation is entitled: “Synovial fluid microRNA biomarkers [...]

Webinar Announcement

🔬 Join us For Our Upcoming Webinar with BioEcho Life Sciences In this session, we'll explore: Discover how TAmiRNA’s miND® small RNA-sequencing assay enables absolute quantification and quality control through synthetic spike-ins, making it a powerful tool for transcriptomic profiling in challenging samples. Learn about the BioEcho EchoLUTION FFPE RNA extraction kit, which preserves the integrity of small and large RNAs to maximize sensitivity [...]

Unlocking the Next Generation of Biomarkers: Introducing TAmiRNA’s New circRNA Analysis Service

The world of non-coding RNAs is continually expanding, revealing new layers of biological complexity and therapeutic potential. Among the most exciting discoveries are circular RNAs (circRNAs). Unlike their linear counterparts, circRNAs form covalently closed loops, granting them remarkable stability and unique functions in gene regulation. This intrinsic stability, coupled with their presence in biofluids, positions circRNAs as powerful new candidates for biomarker discovery [...]

By |June 26th, 2025|Categories: biomarker, Biomarker Discovery, biomarkers, circRNA analysis service, liquid biopsies, microRNAs, NGS, small RNA-sequencing|Tags: , , , , , |Comments Off on Unlocking the Next Generation of Biomarkers: Introducing TAmiRNA’s New circRNA Analysis Service

Transcriptomics Webinar Announcement

🔬 Join us for an insightful transcriptomics webinar where we will delve into cutting-edge strategies for biomarker discovery, basic research, and translational applications. Whether you're focused on diagnostics or overcoming the challenges of low-input sample analysis, this webinar is designed for you! Title: Harnessing Transcriptomics: microRNA and mRNA analysis for Biomarker Discovery, Basic Research, and Translational Applications What to Expect: Comprehensive Transcriptomics Sequencing Services [...]

By |May 8th, 2025|Categories: biomarker, Biomarker Discovery, biomarkers, microRNAs, NGS, small RNA-sequencing|Tags: , , , , , |Comments Off on Transcriptomics Webinar Announcement

EVscale™ and TAmiRNA at ISEV Vienna, April 24-27, 2025

We are thrilled to announce that TAmiRNA, Evercyte, and Phoenestra have united to form EVscale™, a powerful collaboration dedicated to providing comprehensive solutions for extracellular vesicle (EV) research, diagnostic, and therapeutic development. We will be exhibiting at the prestigious ISEV (International Society for Extracellular Vesicles) Conference in Vienna from April 24-27, 2025, and we invite you to visit us at Booth B13. The [...]

By |March 27th, 2025|Categories: biomarker, biomarkers, Evercyte, EVscale, extracellular vesicle, microRNAs, Personalized medicine, smallRNA|Tags: , , , , , , , |Comments Off on EVscale™ and TAmiRNA at ISEV Vienna, April 24-27, 2025

TAmiRNA and Medical University of Vienna Advance Liver Surgery Safety with hepatomiR®

TAmiRNA has joined forces with the Medical University of Vienna to develop an innovative microRNA test (hepatomiR®) to improve safety in liver surgery. The pioneering qPCR-based test is founded on original research by two of the university’s associate professors, Dr. Alice Assinger, Head of the Vienna Platelet Lab, and Dr. Patrick Starlinger, who heads the university’s TELL Translational and Experimental Liver Laboratory. Their [...]

By |February 20th, 2025|Categories: biomarker, biomarkers, CE-IVD, hepatomiR kit, Liver disease, microRNAs, MUW, Personalized medicine, smallRNA|Tags: , , , , , |Comments Off on TAmiRNA and Medical University of Vienna Advance Liver Surgery Safety with hepatomiR®
Go to Top